MORGAN STANLEY - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Arbutus Biopharma Corp (ABUS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Arbutus Biopharma Corp Common Shares
Symbol
ABUS
Shares outstanding
189M shares
Disclosed Ownership
21.5M shares
Ownership
11.4%
Form type
SCHEDULE 13G/A
Date filed
2/3/2025, 03:26 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 11.4% 21.5M 0 21.5M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Investment Management Inc. 11.2% 21.2M 0 21.2M Deidre A Downes Authorized Signatory, Morgan Stanley Investment Management Inc.